La presentazione è in caricamento. Aspetta per favore

La presentazione è in caricamento. Aspetta per favore

Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party.

Presentazioni simili


Presentazione sul tema: "Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party."— Transcript della presentazione:

1 Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis by Simona Luatti, Fausto Castagnetti, Giulia Marzocchi, Carmen Baldazzi, Gabriele Gugliotta, Ilaria Iacobucci, Giorgina Specchia, Lucia Zanatta, Giovanna Rege- Cambrin, Marco Mancini, Elisabetta Abruzzese, Alfonso Zaccaria, Maria Grazia Grimoldi, Alessandro Gozzetti, Gaia Ameli, Maria Adele Capucci, Giandomenico Palka, Paolo Bernasconi, Francesca Palandri, Fabrizio Pane, Giuseppe Saglio, Giovanni Martinelli, Gianantonio Rosti, Michele Baccarani, and Nicoletta Testoni Blood Volume 120(4):761-767 July 26, 2012 ©2012 by American Society of Hematology

2 Cytogenetic and molecular response. Simona Luatti et al. Blood 2012;120:761-767 ©2012 by American Society of Hematology

3 Long-term outcome. Simona Luatti et al. Blood 2012;120:761-767 ©2012 by American Society of Hematology


Scaricare ppt "Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party."

Presentazioni simili


Annunci Google